Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)

Recruiting N/A Interventional Study
Covid19 Arterial Stiffness Endothelial Dysfunction Diastolic Dysfunction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
360 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age \>18 years, both sexes; * written informed consent; * affiliation to a social security regime; * a recent diagnosis of COVID19 (6±3 months) proven by PCR or serology (for group 1,2,3) * hospitalization in intensive care unit for COVID19 (for group 1) * hospitalization in a…
Contacts

Rosa Maria BRUNO, MD

+33 1 53 98 79 67

rosa-maria.bruno@inserm.fr

CONTACT

Laura LE MAO, MSc

+33 1 56 09 54 97

laura.le-mao@aphp.fr

CONTACT